| Metal Powder Works Limited (MPW) ORDINARY FULLY PAID |
Industrials |
$23 |
MPW CP Titanium Validated in Cold Spray Applications by HAMR
|
1 Sep 2025 8:28AM |
$3.650 |
$4.100 |
risen by
12.33%
|
|
MPW - Price-sensitive ASX Announcement
Full Release
Key Points
- MPW's CP-Ti powder validated for cold spray applications by HAMR Industries.
- The powder meets industry handbook values equivalent to wrought titanium.
- MPW employs an innovative non-thermal DirectPowder™ process.
- The process offers cost-effective, high-performance powder production.
- Targeting strategic CP-Ti market valued at USD 847 million.
- Applications include aerospace, medical, and marine industries.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NAOS Ex-50 Opportunities Company Limited (NAC) ORDINARY FULLY PAID |
Financials |
$24 |
Invitation to NAOS Investor Roadshow
|
1 Sep 2025 8:28AM |
$0.580 |
$0.530 |
fallen by
8.62%
|
|
| Latitude Group Holdings Limited (LFS) ORDINARY FULLY PAID |
Financials |
$1,190 |
Update - Notification of buy-back - LFSPA
|
1 Sep 2025 8:28AM |
$1.160 |
$1.145 |
fallen by
1.29%
|
|
| Straker Limited (STG) ORDINARY FULLY PAID |
Industrials |
$22 |
Initial Director's Interest Notice - Ron Heinz
|
1 Sep 2025 8:28AM |
$0.390 |
$0.345 |
fallen by
11.54%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,013 |
Net Tangible Asset Backing
|
1 Sep 2025 8:28AM |
$3.200 |
$3.200 |
fallen by
0%
|
|
| BETR Entertainment Limited (BBT) ORDINARY FULLY PAID |
Consumer Discretionary |
$274 |
Change in Substantial Holding for PBH
|
1 Sep 2025 8:28AM |
$0.300 |
$0.265 |
fallen by
11.67%
|
|
| Pointsbet Holdings Limited (PBH) ORDINARY FULLY PAID |
Consumer Discretionary |
$434 |
Change in Substantial Holding from BBT
|
1 Sep 2025 8:28AM |
$1.260 |
$1.250 |
fallen by
0.79%
|
|
| Victory Metals Limited (VTM) ORDINARY FULLY PAID |
Materials |
$157 |
Application for quotation of securities - VTM
|
1 Sep 2025 8:28AM |
$1.365 |
$1.200 |
fallen by
12.09%
|
|
| Smart Parking Limited (SPZ) ORDINARY FULLY PAID |
Industrials |
$381 |
Change of Director's Interest Notice
|
1 Sep 2025 8:28AM |
$0.995 |
$0.930 |
fallen by
6.53%
|
|
| Carbonxt Group Limited (CG1) ORDINARY FULLY PAID |
Materials |
$27 |
Despatch of letter to ineligible shareholders
|
1 Sep 2025 8:27AM |
$0.060 |
$0.065 |
risen by
8.33%
|
|
| Credit Corp Group Limited (CCP) ORDINARY FULLY PAID |
Financials |
$1,106 |
Upcoming Annual General Meeting
|
1 Sep 2025 8:27AM |
$16.500 |
$16.255 |
fallen by
1.48%
|
|
| Carbonxt Group Limited (CG1) ORDINARY FULLY PAID |
Materials |
$27 |
Despatch of entitlement offer documents
|
1 Sep 2025 8:27AM |
$0.060 |
$0.065 |
risen by
8.33%
|
|
| Credit Corp Group Limited (CCP) ORDINARY FULLY PAID |
Financials |
$1,106 |
Change to timing of appointment of Non-Executive Director
|
1 Sep 2025 8:27AM |
$16.500 |
$16.255 |
fallen by
1.48%
|
|
| Osteopore Limited (OSX) ORDINARY FULLY PAID |
Health Care |
$3 |
OSX Invests AUD 0.5m in Cellular Regenerative Medicine
|
1 Sep 2025 8:27AM |
$0.012 |
$0.012 |
fallen by
4.17%
|
|
OSX - Price-sensitive ASX Announcement
Full Release
Key Points
- Osteopore Limited invests AUD 0.5m in establishing OsteoRx.
- OsteoRx focuses on cellular regeneration and longevity science.
- Renowned scientists Dr. Xianmin Zeng and Dr. Brian Kennedy to lead OsteoRx.
- Investment includes a controlling stake in RxCell Inc.
- Enhances Osteopore's role in the USD 19.34b stem cell market.
- Aims to develop therapies addressing age-related degeneration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Osteopore Limited (OSX) ORDINARY FULLY PAID |
Health Care |
$3 |
OSX Invests AUD 0.5m in Cellular Regenerative Medicine
|
1 Sep 2025 8:27AM |
$0.012 |
$0.012 |
fallen by
4.17%
|
|
OSX - Price-sensitive ASX Announcement
Full Release
Key Points
- Osteopore Limited makes a strategic AUD 0.5 million investment in cellular regenerative medicine.
- The investment is directed towards OsteoRx, a special purpose vehicle focused on biotech and medtech integration.
- OsteoRx aims to drive breakthroughs in tissue regeneration, disease cures, and longevity.
- A controlling stake in RxCell Inc, a leading iPSC company, will be incorporated into OsteoRx.
- Renowned scientists Dr. Xianmin Zeng and Dr. Brian Kennedy are co-owners in the OsteoRx venture.
- The move enhances Osteopore's leadership in regenerative medicine and expands its market exposure.
- Osteopore's investment is expected to catalyze operations and platform development in OsteoRx.
- The stem cell market, where OsteoRx will operate, is projected to grow significantly by 2032.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NAOS Small Cap Opportunities Company Limited (NSC) ORDINARY FULLY PAID |
Financials |
$45 |
Invitation to NAOS Investor Roadshow
|
1 Sep 2025 8:26AM |
$0.365 |
$0.340 |
fallen by
6.85%
|
|
| Naos Emerging Opportunities Company Limited (NCC) ORDINARY FULLY PAID |
Financials |
$29 |
Invitation to NAOS Investor Roadshow
|
1 Sep 2025 8:26AM |
$0.375 |
$0.390 |
risen by
4%
|
|
| Native Mineral Resources Holdings Limited (NMR) ORDINARY FULLY PAID |
Materials |
$132 |
NMR delivers updated Mineral Resource for Granite Castle
|
1 Sep 2025 8:26AM |
$0.135 |
$0.135 |
fallen by
0%
|
|
NMR - Price-sensitive ASX Announcement
Full Release
Key Points
- Native Mineral Resources Holdings Limited (NMR) is focused on the Granite Castle Gold Project.
- The updated Mineral Resource estimates for Granite Castle include a reduction in tonnes but an increase in gold grade.
- No significant mining activities have taken place at the Granite Castle site.
- There is some uncertainty in local estimates due to current drillhole spacing and geological complexities.
- Further geological and metallurgical studies are planned to enhance the accuracy of the resource estimates.
- The Granite Castle site hosts both sulphide and oxide/transition materials.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Native Mineral Resources Holdings Limited (NMR) ORDINARY FULLY PAID |
Materials |
$132 |
NMR delivers updated Mineral Resource for Granite Castle
|
1 Sep 2025 8:26AM |
$0.135 |
$0.135 |
fallen by
0%
|
|
NMR - Price-sensitive ASX Announcement
Full Release
Key Points
- The updated Mineral Resource for Granite Castle is presented by Native Mineral Resources Holdings Limited.
- The resource estimates are considered accurate globally, but there's uncertainty in local estimates due to drillhole spacing and geological complexities.
- A significant reduction in tonnes and an increase in gold grade compared to the 2008 estimates.
- The Mineral Resource reporting is now limited to 560mRL, compared to the previous 420mRL.
- There has been no significant mining of the deposit.
- The 2025 estimate shows a 26% decrease in tonnes but a 10% increase in gold grade compared to the 2008 estimate.
- Block model validation did not indicate any issues.
- The Competent Person's experience with similar deposits supports the stated accuracy and confidence levels.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Caspin Resources Limited (CPN) ORDINARY FULLY PAID |
Materials |
$11 |
Maiden Resource Estimate at Bygoo Tin Project
|
1 Sep 2025 8:26AM |
$0.052 |
$0.061 |
risen by
17.31%
|
|
CPN - Price-sensitive ASX Announcement
Full Release
Key Points
- Maiden Inferred resource estimate of 3.94 million tonnes at 0.5% Sn.
- Contained tin of 19,300 tonnes within an open pit constraint.
- Exploration Target suggests potential to more than double the resource size.
- Kelpie Deposit forms a small part of a larger prospective granite horizon.
- Historical workings and rock chip samples indicate extensive mineralisation.
- Plans for further exploration and extension of mineralisation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Caspin Resources Limited (CPN) ORDINARY FULLY PAID |
Materials |
$11 |
Maiden Resource Estimate at Bygoo Tin Project
|
1 Sep 2025 8:26AM |
$0.052 |
$0.061 |
risen by
17.31%
|
|
CPN - Price-sensitive ASX Announcement
Full Release
Key Points
- Maiden Resource Estimate provides foundation for mining project.
- Project located in Lachlan Fold Belt, part of Wagga Tin Belt.
- Inferred Mineral Resource identified with optimized pit shell.
- Potential for growth beyond current Kelpie resource.
- Drilling techniques and sample analyses adhere to industry standards.
- Strong exploration potential highlighted.
- Statements from competent persons on resource estimate reliability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| 4DMedical Limited (4DX) ORDINARY FULLY PAID |
Health Care |
$896 |
4DMedical receives FDA clearance for CTVQ
|
1 Sep 2025 8:26AM |
$0.570 |
$1.910 |
risen by
235.09%
|
|
4DX - Price-sensitive ASX Announcement
Full Release
Key Points
- 4DMedical's CT:VQ™ receives FDA 510(k) clearance
- World's first non-contrast, CT-based VQ imaging technology
- Eliminates need for radiotracers, streamlining scheduling and improving access
- Potential to replace traditional nuclear VQ scans
- Initial market opportunity of over USD $1.1 billion in the U.S.
- Compatible with approximately 14,500 CT scanners in the U.S.
- Enhances diagnostic capabilities in smaller and rural facilities
- Extensive clinical validation package supports FDA submission
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| 4DMedical Limited (4DX) ORDINARY FULLY PAID |
Health Care |
$896 |
4DMedical receives FDA clearance for CTVQ
|
1 Sep 2025 8:26AM |
$0.570 |
$1.910 |
risen by
235.09%
|
|
4DX - Price-sensitive ASX Announcement
Full Release
Key Points
- 4DMedical's CT:VQ™ receives FDA 510(k) clearance.
- CT:VQ™ is the first non-contrast, CT-based VQ imaging technology.
- The technology extracts quantitative VQ data from standard CT scans.
- CT:VQ™ eliminates the need for radiotracers and offers better image resolution.
- The U.S. market opportunity for CT:VQ™ is over $1.1 billion annually.
- CT:VQ™ can potentially replace all nuclear VQ scans in the U.S.
- Extensive clinical testing shows CT:VQ™ matches current SPECT standards.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ainsworth Game Technology Limited (AGI) ORDINARY FULLY PAID |
Consumer Discretionary |
$364 |
Becoming a substantial holder
|
1 Sep 2025 8:25AM |
$1.015 |
$1.080 |
risen by
6.40%
|
|
| Laserbond Limited (LBL) ORDINARY FULLY PAID |
Industrials |
$60 |
Final Director's Interest Notice
|
1 Sep 2025 8:25AM |
$0.505 |
$0.510 |
risen by
0.99%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
